Cargando…

Psychometric Validation of a Japanese Version of the emPHasis-10 Questionnaire, a Patient-Reported Outcome Measure for Pulmonary Hypertension　― Multicenter Study in Japan ―

Background: The emPHasis-10 questionnaire is a disease-specific patient-reported outcome assessment of quality of life (QOL) in pulmonary hypertension (PH). The aim of this study was to psychometrically validate a linguistically validated Japanese version of the emPHasis-10. Methods and Results: Jap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeyasu, Rika, Tamura, Yuichi, Abe, Kohtaro, Goda, Ayumi, Satoh, Toru, Suda, Rika, Tanabe, Nobuhiro, Tsujino, Ichizo, Yamazaki, Tsutomu, Tatsumi, Koichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Circulation Society 2020
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921356/ https://www.ncbi.nlm.nih.gov/pubmed/33693238 http://dx.doi.org/10.1253/circrep.CR-20-0014

Ejemplares similares

EmPHasis‐10 Health‐Related Quality of Life and Exercise Capacity in Chronic Thromboembolic Pulmonary Hypertension After Balloon Angioplasty
por: Sakamoto, Hayato, et al.
Publicado: (2022)

emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension
por: Yorke, Janelle, et al.
Publicado: (2014)

Improvements in French risk stratification score were correlated with reductions in mean pulmonary artery pressure in pulmonary arterial hypertension: a subanalysis of the Japan Pulmonary Hypertension Registry (JAPHR)
por: Tamura, Yuichi, et al.
Publicado: (2021)

SATISFY‐JP, a phase II multicenter open‐label study on Satralizumab, an anti‐IL‐6 receptor antibody, use for the treatment of pulmonary arterial hypertension in patients with an immune‐responsive‐phenotype: Study protocol
por: Tamura, Yuichi, et al.
Publicado: (2023)

Correlating between chronic obstructive pulmonary disease assessment test and emPHasis score in Group III pulmonary hypertension patients
por: Sengupta, Sayoni, et al.
Publicado: (2019)

The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan
por: Takahashi, Yukiko, et al.
Publicado: (2021)

Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in Japan
por: Tamura, Yuichi, et al.
Publicado: (2022)

Characteristics of patients meeting the new definition of pre-capillary pulmonary hypertension (Nice 2018) in a single Japanese pulmonary hypertension center
por: Yamamoto, Keiko, et al.
Publicado: (2021)

Cross-cultural validation of the Chinese version of the EmPHasis-10 questionnaire in connective tissue disease patients with pulmonary arterial hypertension and its relationship with risk stratification
por: Shi, Yue, et al.
Publicado: (2022)

Nocturnal Hypoxemia and High Circulating TNF-α Levels in Chronic Thromboembolic Pulmonary Hypertension
por: Naito, Akira, et al.
Publicado: (2020)

Heritable pulmonary arterial hypertension complicated by multiple pulmonary arteriovenous malformations
por: Arano, Takahiro, et al.
Publicado: (2021)

Vascular involvement in chronic thromboembolic pulmonary hypertension is associated with spirometry obstructive impairment
por: Yanagisawa, Asako, et al.
Publicado: (2021)

Impact of residual pulmonary hypertension on long‐term outcomes after pulmonary endarterectomy in the modern era
por: Ishida, Keiichi, et al.
Publicado: (2023)

EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study
por: Lewis, Robert A., et al.
Publicado: (2021)

Clinical characteristics and prognosis in patients with chronic thromboembolic pulmonary hypertension and a concomitant psychiatric disorder
por: Tajima, Hiroshi, et al.
Publicado: (2019)

Biogenesis of reproductive PhasiRNAs: exceptions to the rules
por: Zheng, Jiakun, et al.
Publicado: (2022)

The anticoagulant effects of warfarin and the bleeding risk associated with its use in patients with chronic thromboembolic pulmonary hypertension at a specialist center in Japan: a retrospective cohort study
por: Jujo-Sanada, Takayuki, et al.
Publicado: (2017)

24-nt reproductive phasiRNAs are broadly present in angiosperms
por: Xia, Rui, et al.
Publicado: (2019)

Characterization of pulmonary intimal sarcoma cells isolated from a surgical specimen: In vitro and in vivo study
por: Sanada, Takayuki Jujo, et al.
Publicado: (2019)

Selexipag for the treatment of chronic thromboembolic pulmonary hypertension
por: Ogo, Takeshi, et al.
Publicado: (2022)

Altered gut microbiota and its association with inflammation in patients with chronic thromboembolic pulmonary hypertension: a single-center observational study in Japan
por: Ikubo, Yumiko, et al.
Publicado: (2022)

Partial anomalous pulmonary venous return with dual drainage to the superior vena cava and left atrium with pulmonary hypertension
por: Tanaka, Nozomi, et al.
Publicado: (2018)

Involvement of pulmonary arteriopathy in the development and severity of reperfusion pulmonary edema after pulmonary endarterectomy
por: Sanada, Takayuki Jujo, et al.
Publicado: (2019)

Spatial distribution of three ARGONAUTEs regulates the anther phasiRNA pathway
por: Tamotsu, Hinako, et al.
Publicado: (2023)

Gut microbiota modification suppresses the development of pulmonary arterial hypertension in an SU5416/hypoxia rat model
por: Sanada, Takayuki J., et al.
Publicado: (2020)

The extent of enlarged bronchial arteries is not correlated with the development of reperfusion pulmonary edema after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension
por: Ikubo, Yumiko, et al.
Publicado: (2020)

A Small RNA-Mediated Regulatory Network in Arabidopsis thaliana Demonstrates Connectivity Between phasiRNA Regulatory Modules and Extensive Co-Regulation of Transcription by miRNAs and phasiRNAs
por: Vargas-Asencio, Jose A., et al.
Publicado: (2020)

“I’ll Try My Best to be a Dad”: The Experiences of Japanese Fathers with Cancer
por: Tamura, Rika, et al.
Publicado: (2021)

Novel Meiotic miRNAs and Indications for a Role of PhasiRNAs in Meiosis
por: Dukowic-Schulze, Stefanie, et al.
Publicado: (2016)

Reproductive phasiRNAs regulate reprogramming of gene expression and meiotic progression in rice
por: Zhang, Yu-Chan, et al.
Publicado: (2020)

Degradome sequencing-based identification of phasiRNAs biogenesis pathways in Oryza sativa
por: Yu, Lan, et al.
Publicado: (2021)

How COVID-19 Affected the Introduction of Telemedicine and Patient Reported Outcomes Among Patients With Pulmonary Hypertension　― A Report From a Referral Center in Japan ―
por: Tamura, Yuichi, et al.
Publicado: (2020)

Case Report: BMPR2-Targeted MinION Sequencing as a Tool for Genetic Analysis in Patients With Pulmonary Arterial Hypertension
por: Takashima, Tomoya, et al.
Publicado: (2021)

Hypoxic Pulmonary Vasoconstriction and the Diffusing Capacity in Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis
por: Sakao, Seiichiro, et al.
Publicado: (2019)

A genome-wide association analysis identifies PDE1A|DNAJC10 locus on chromosome 2 associated with idiopathic pulmonary arterial hypertension in a Japanese population
por: Kimura, Mai, et al.
Publicado: (2017)

Biogenesis of diverse plant phasiRNAs involves an miRNA-trigger and Dicer-processing
por: Komiya, Reina
Publicado: (2016)

Corrigendum: Novel Meiotic miRNAs and Indications for a Role of PhasiRNAs in Meiosis
por: Dukowic-Schulze, Stefanie, et al.
Publicado: (2020)

Clinical Management and Outcomes of Patients With Portopulmonary Hypertension Enrolled in the Japanese Multicenter Registry
por: Tamura, Yudai, et al.
Publicado: (2022)

Identification of tRFs and phasiRNAs in tomato (Solanum lycopersicum) and their responses to exogenous abscisic acid
por: Luan, Wei, et al.
Publicado: (2020)

Abundance of Phasi-Charoen-like virus in Aedes aegypti mosquito populations in different states of India
por: Lole, Kavita, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2edl1q8qjos6vhod31luhqb7or